Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study

Title
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study
Authors
Keywords
-
Journal
BLOOD
Volume -, Issue -, Pages blood-2018-09-876805
Publisher
American Society of Hematology
Online
2018-12-04
DOI
10.1182/blood-2018-09-876805

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search